Category: Updates

WOMEN AND LAW – AN ASSESSMENT : Indira Jaising

INTRODUCTION The Indian Constitution, adopted in 1950, at a time when fundamental rights were formally being guaranteed all over the world to meet the demands of a post-Holocaust era was truly a child of the post Second World War period. Naturally, like other sister documents, it was necessarily influenced by...

Read More

Bhopal gas leak tragedy: Disaster in progress : Indira Jaising

Sathyu (left) went to Bhopal as a volunteer a day after the gas leak and never left. Today, he is a founder member of the Bhopal Group for Information and Action and the Sambhavna Trust. ______________________________________________________________________________________________________________________________________ On the 30th anniversary of the Bhopal disaster, memories of the victims’ suffering surface...

Read More

Concern for the Dead, Condemnation for the Living : Indira Jaising

INDIRA JAISING While ruling that women were increasingly misusing Section 498A of the Indian Penal Code, the Supreme Court ought to have been more conscious of the prevalence of domestic violence, and the difficulties women face in approaching the police. When faced with evidence of a poor conviction rate, instead...

Read More

Convicts can’t be hanged secretly and hurriedly: Supreme Court

NEW DELHI: Condemned prisoners also have a right to dignity, the Supreme Court has said holding that execution of death sentence cannot be carried out in an arbitrary, hurried and secret manner without allowing death row convicts to exhaust all legal remedies and meet family members. “Right to life under...

Read More

Civil society groups strike again: BMS’ patent bid for Hep C treatment Daclatasvir challenged

2 May 2015: Stepping up efforts to counter patents on life-saving medicines, three civil society groups working to increase access to affordable, life-saving Hepatitis C (HCV) medicines, have challenged Bristol-Myers Squibb (BMS’) pending patent application on Daclatasvir before the Delhi Patent Office. The pre-grant opposition has been filed by Hepatitis...

Read More

Community groups take on Gilead’s monopoly of life-saving medicines

Fourth pre-grant opposition to Sofosbuvir filed in the Delhi Patent Office 30 January 2015, Delhi: Stepping up efforts to ensure the access to affordable and effective treatment for people living with Hepatitis C (HCV) in India and the rest of the world, another pre-grant opposition to Gilead’s patent application on...

Read More

Supreme Court says no to Bayer, upholds compulsory license on Nexavar

December 12, 2014 In a momentous decision that would have wide-ranging implication for access to medicines, the Supreme Court of India refused to entertain Bayer’s appeal to set aside the compulsory license (CL) on Sorafenib (Nexavar). The Supreme Court’s dismissal of Bayer’s Special Leave Petition against the Bombay High Court’s...

Read More
Page 3 of 1212345...10...Last »